Atyr Pharma Inc (ATYR) Stock Price, Quote & News

Company Profile

aTyr Pharma, Inc., a clinical stage biotechnology company, engages in the discovery and development of product candidates that translate tRNA synthetase biology into new therapies for fibrosis and inflammation in the United States. Its lead therapeutic candidate efzofitimod, a selective modulator of NRP2 that is in Phase 3 clinical trial for the treatment of pulmonary sarcoidosis; Phase 2 clinical trial to treat Sarcoidosis and systemic sclerosis- interstitial lung disease (ILDs); and treatment...

Industry: Biotechnology

Sector: Healthcare

Phone: 858 731 8389

Fax: 858 731 8394

Website: atyrpharma.com

Address:

10240 Sorrento Valley Road, Suite 300, San Diego, United States

tedypa Jul. 5 at 10:57 PM

$ATYR I'm expecting IND today!

0 · Reply

MilkingAlgosEveryMonday Jul. 4 at 6:42 AM

$OTLK $VG $ATYR

0 · Reply

saneguy Jul. 2 at 8:38 AM

$ATYR damn….85 average and no news at all… 30k at stake

0 · Reply

JoNCherry Jul. 2 at 3:35 AM

$ATYR End of June

0 · Reply

stefano62 Jul. 1 at 2:44 PM

$ATYR still no rumors about the new IND that should have been submitted by the end of June?

0 · Reply

HansDampf1 Jul. 1 at 2:13 PM

$ATYR AmericanBulls recognizes a BUY Signal 😄 https://www.americanbulls.com/SignalPage.aspx?lang=en&Ticker=ATYR

0 · Reply

X600X Jun. 30 at 9:28 PM

$ATYR $SLS Look ag this post! The Short's and 'Stop loss'.

0 · Reply

mido89 Jun. 30 at 9:07 PM

$ATYR finally we are above 0.6$ 🚀🚀

0 · Reply

stefano62 Jun. 30 at 5:11 PM

$ATYR today should be the day tò announce the official submission of new IND.....

1 · Reply

mido89 Jun. 30 at 4:51 PM

$ATYR need to break 0.6$ in order to see the 1$

0 · Reply

Ethos to Announce Second Quarter 2026 Financial Results on August 3, 2026

LIFE

Jun 25, 2026, 3:30 PM EDT - 10 days ago

aTyr Pharma Transcript: Life Sciences Virtual Investor Forum

Jun 4, 2026, 3:45 PM EDT - 4 weeks ago

aTyr Pharma Transcript: Jefferies Global Healthcare Conference 2026

May 26, 2026, 3:08 PM EDT - 5 weeks ago

Forget the SpaceX IPO. These 2 New Stocks Stand Out Right Now.

LIFE PTRN

May 21, 2026, 9:07 AM EDT - 6 weeks ago

Ethos Partners with Baseball Legend David Ortiz to Champion Life Insurance as a Family Financial Essential

LIFE

2026-05-20T13:00:12.000Z - 6 weeks ago

aTyr Pharma upgraded to Buy from Hold at Freedom Broker

May 15, 2026, 4:30 PM EDT - 7 weeks ago

Ethos to Present at Upcoming Investor Conferences

LIFE

2026-05-15T15:42:31.000Z - 7 weeks ago

aTyr Pharma reports Q1 EPS (11c), consensus (15c)

May 15, 2026, 8:00 AM EDT - 7 weeks ago

aTyr Pharma Announces First Quarter 2026 Results and Provides Corporate Update

May 15, 2026, 7:00 AM EDT - 7 weeks ago

aTyr Pharma Quarterly report: Q1 2026

May 15, 2026, 7:00 AM EDT - 7 weeks ago

aTyr Pharma Earnings release: Q1 2026

May 13, 2026, 4:35 PM EDT - 7 weeks ago

Ethos Announces Early Lock-Up Release

LIFE

May 13, 2026, 4:01 PM EDT - 7 weeks ago

aTyr Pharma to Participate in Upcoming Investor Conferences

2026-05-11T23:05:03.000Z - 7 weeks ago

aTyr Pharma provides regulatory update on efzofitimod following Type C meeting

May 11, 2026, 4:30 PM EDT - 7 weeks ago

aTyr Pharma Transcript: Study update

May 11, 2026, 4:30 PM EDT - 7 weeks ago

aTyr Pharma Press release: Study update

May 11, 2026, 4:30 PM EDT - 7 weeks ago

aTyr Pharma Slides: Study update

May 11, 2026, 4:01 PM EDT - 7 weeks ago

aTyr Pharma Provides Regulatory and Clinical Update for Efzofitimod in Pulmonary Sarcoidosis Following FDA Type C Meeting

May 6, 2026, 4:05 PM EDT - 2 months ago

Ethos Reports First Quarter Fiscal Year 2026 Financial Results

LIFE

May 5, 2026, 9:07 AM EDT - 2 months ago

Ethos Launches ChatGPT App To Bring Instant Life Insurance Estimates to 900 Million Users

LIFE

Apr 23, 2026, 9:07 AM EDT - 2 months ago

Ethos Collaborates with Liberty Mutual to Deliver a Modern, Digital-First Life Insurance Experience

LIFE

Apr 2, 2026, 4:05 PM EDT - 3 months ago

Ethos to Announce First Quarter 2026 Financial Results on May 6, 2026

LIFE

Mar 26, 2026, 8:00 AM EDT - 3 months ago

aTyr Pharma Proxy statement: Proxy filing

Mar 26, 2026, 8:00 AM EDT - 3 months ago

aTyr Pharma Proxy statement: Proxy filing

Mar 24, 2026, 4:05 PM EDT - 3 months ago

Ethos and Banner Life Expand Offering to Bring Final Expense Coverage to More Families

LIFE

Mar 12, 2026, 8:00 AM EDT - 4 months ago

aTyr Pharma Proxy statement: Proxy Filing

Mar 11, 2026, 8:00 AM EDT - 4 months ago

aTyr Pharma Transcript: Leerink Global Healthcare Conference 2026

2026-03-05T21:05:56.000Z - 4 months ago

aTyr Pharma reports Q4 EPS (14c), consensus (17c)

Mar 5, 2026, 4:01 PM EST - 4 months ago

aTyr Pharma Announces Fourth Quarter and Full Year 2025 Results and Provides Corporate Update

Mar 5, 2026, 3:00 PM EST - 4 months ago

aTyr Pharma Annual report: Q4 2025

Mar 5, 2026, 3:00 PM EST - 4 months ago

aTyr Pharma Earnings release: Q4 2025

Feb 26, 2026, 4:06 PM EST - 4 months ago

Ethos to Participate in The Citizens Technology Conference

LIFE

Feb 25, 2026, 4:05 PM EST - 4 months ago

Ethos Reports Fourth Quarter and Fiscal Year 2025 Financial Results

LIFE

Feb 20, 2026, 4:01 PM EST - 4 months ago

aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Feb 18, 2026, 8:00 AM EST - 4 months ago

aTyr Pharma to Present at the Leerink Partners Global Healthcare Conference

Feb 5, 2026, 4:05 PM EST - 5 months ago

Ethos to Announce Fourth Quarter 2025 Financial Results on February 25, 2026

LIFE

Feb 3, 2026, 2:46 PM EST - 5 months ago

The IPO Market Faces a Busy Week. These Stocks Are Making Their Debuts.

FPS LFTO YSS

2026-02-03T13:10:35.000Z - 5 months ago

aTyr Pharma announces U.S. FDA accepted meeting request for efzofitimod

Feb 3, 2026, 8:00 AM EST - 5 months ago

aTyr Pharma Announces Scheduling of FDA Type C Meeting to Discuss Efzofitimod Program in Pulmonary Sarcoidosis

Jan 29, 2026, 12:30 PM EST - 5 months ago

Insurance platform Ethos Technologies valued at $1.2 billion in Nasdaq debut

Jan 28, 2026, 10:38 PM EST - 5 months ago

Ethos Announces Pricing of Initial Public Offering

Jan 28, 2026, 9:05 PM EST - 5 months ago

Ethos Technologies prices US IPO at $19/share, Bloomberg News reports

Jan 7, 2026, 8:01 AM EST - 6 months ago

Ethos and North American Collaborate to Offer Accumulation Indexed Universal Life Product

Dec 18, 2025, 8:01 AM EST - 7 months ago

Ethos and Aflac Partner to Bring Supplemental Health Product Suite to Independent Distribution

Dec 15, 2025, 2:45 PM EST - 7 months ago

Johnson Fistel Investigates Claims on Behalf of aTyr Pharma, Inc. (ATYR) Shareholders

Dec 8, 2025, 3:25 AM EST - 7 months ago

aTyr Pharma, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - ATYR

Dec 2, 2025, 1:00 PM EST - 7 months ago

aTyr Pharma Transcript: Piper Sandler 37th Annual Healthcare Conference

2025-11-25T15:09:57.000Z - 7 months ago

aTyr Pharma Faces Class Action after Clinical Trial Failure Raises Investor Concerns

2025-11-06T21:26:32.000Z - 8 months ago

aTyr Pharma reports Q3 EPS (26c), consensus (18c)

Nov 6, 2025, 4:00 PM EST - 8 months ago

aTyr Pharma Earnings release: Q3 2025

Nov 6, 2025, 4:00 PM EST - 8 months ago

aTyr Pharma Quarterly report: Q3 2025

2025-09-30T10:20:48.000Z - 9 months ago

aTyr Pharma reports clinical benefit for efzofitimod across multiple diseases

2025-09-29T20:40:08.000Z - 9 months ago

Piper Sandler healthcare analysts hold an analyst/industry conference call

2025-09-15T20:30:25.000Z - 10 months ago

aTyr Pharma downgraded to Sector Perform from Outperform at RBC Capital

2025-09-15T18:00:09.000Z - 10 months ago

Wells Fargo downgrades aTyr Pharma on efzofitimod Phase 3 failure

tedypa Jul. 5 at 10:57 PM

$ATYR I'm expecting IND today!

0 · Reply

MilkingAlgosEveryMonday Jul. 4 at 6:42 AM

$OTLK $VG $ATYR

0 · Reply

saneguy Jul. 2 at 8:38 AM

$ATYR damn….85 average and no news at all… 30k at stake

0 · Reply

JoNCherry Jul. 2 at 3:35 AM

$ATYR End of June

0 · Reply

stefano62 Jul. 1 at 2:44 PM

$ATYR still no rumors about the new IND that should have been submitted by the end of June?

0 · Reply

HansDampf1 Jul. 1 at 2:13 PM

$ATYR AmericanBulls recognizes a BUY Signal 😄 https://www.americanbulls.com/SignalPage.aspx?lang=en&Ticker=ATYR

0 · Reply

X600X Jun. 30 at 9:28 PM

$ATYR $SLS Look ag this post! The Short's and 'Stop loss'.

0 · Reply

mido89 Jun. 30 at 9:07 PM

$ATYR finally we are above 0.6$ 🚀🚀

0 · Reply

stefano62 Jun. 30 at 5:11 PM

$ATYR today should be the day tò announce the official submission of new IND.....

1 · Reply

mido89 Jun. 30 at 4:51 PM

$ATYR need to break 0.6$ in order to see the 1$

0 · Reply

MilkingAlgosEveryMonday Jun. 30 at 2:23 PM

$ATYR maybe you but not $ATYR !

1 · Reply

BillionerOfKing Jun. 29 at 3:35 PM

$ATYR Current Stock Price: $0.55 Contracts to trade: $0.5 ATYR Jul 17 2026 Call Entry: $0.23 Exit: $0.32 ROI: 42% Hold ~28 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

DarkH0rse91 Jun. 29 at 11:33 AM

You know $ATYR is a flop right?

1 · Reply

DarkH0rse91 Jun. 29 at 11:10 AM

$ATYR are you dumb, stupid or dumb?

1 · Reply

MilkingAlgosEveryMonday Jun. 29 at 6:00 AM

$ATYR if you are bearish wtf you doing here??

0 · Reply

DarkH0rse91 Jun. 28 at 9:46 PM

$ATYR $SLS Hey SLS guys, check out ATYR. This will be you guys soon. 'Stop loss' my ass LMAO

5 · Reply

pepeber Jun. 27 at 10:03 AM

$ATYR 10M volume in the last minute ! Awesome

0 · Reply

mido89 Jun. 26 at 6:06 PM

$ATYR why the drop ???

0 · Reply

crankypizza Jun. 26 at 4:54 PM

$ATYR

0 · Reply

lilsilli301 Jun. 26 at 4:11 PM

$ATYR

0 · Reply

MilkingAlgosEveryMonday Jun. 26 at 11:32 AM

$VG $OTLK $ATYR its our money 'GOD' promised us very long time ago.$SPCX keep eyes on otlk 2 day left for golden ticket 'GOD' will.

1 · Reply

ANTI_FUD Jun. 25 at 2:24 PM

$OTLK The countdown to July 29 is ON! 🔥 Labeling discussions are happening, Class 1 review is locked, and the thesis is playing out perfectly. Stay strong, know what you hold, and ignore the daily noise. Keeping a close eye on $ATYR as a sleeper recovery watch while they roll out the new trial design. Let’s finish the summer strong! 💸

1 · Reply

Market Cap	58.10M
Revenue (ttm)	190,000.00
Net Income (ttm)	-74.12M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-39,010.53%
Debt to Equity Ratio	0.00

Volume	1,476,500
Avg Vol	3,006,566
Day's Range	N/A - N/A
Shares Out	98.05M
Stochastic %K	81%
Beta	0.52
Analysts	Sell
Price Target	$2.75